Could this be the biggest news in the treatment of severe COVID so far?

Could this be the biggest news in the treatment of severe COVID so far?

By the way, what these are, the cytokines are small proteins that are involved in cell signaling with the body’s immune system. These so-called storms occur when the body produces way too many cytokines too quickly, so it really wreaks havoc on the body. What happened here though, as NRx said, that Zyesami was also associated with a significant decrease in 60-day mortality. Reducing the number of deaths makes this drug’s appeal even greater. Speights: Yeah, I think this very well could be big news. Preventing these cytokine storms is a big deal. That’s especially the case with the rise in the COVID-19 cases among unvaccinated individuals. I think this really could be excellent news for treatment of severe COVID-19, and probably will increase the likelihood that the FDA does grant emergency use authorization to this drug.

Speights: Yeah. Zitkus: You read it and you realize you’ve never said it aloud before.

Zitkus: That’s where I’m at this morning. Anyway, this experimental drug Zyesami, we’ll call it that. They discovered that it could potentially help prevent cytokine storms in patients with COVID-19. These storms have been a serious issue in treating the disease. Do you think that this could be big news in treating severe COVID, or the biggest since we’ve been following treatment stocks? Keith Speights: Brian and I always struggle over drug names and we just roll with it. We might be right, we might be wrong, we just go with it.

I think investors are saying, “We’re going to wait and see what happens with the FDA.” If the drug wins EUA, I think the stock is going to soar again, but I think everybody’s being really cautious right now. Zitkus: Yeah, rightfully so. This is a $500 million market cap company, and it’s serving as the US collaboration partner for relief therapeutics on this project, so it’s not totally going in alone, but it will be an interesting. I agree with wait-and-see approach, I think I’d be a little afraid of the market wins on this one for now. There have been several advances in treating severe COVID-19, notably including those antibody therapies. My impression is that investors are taking a wait-and-see attitude here. NRx stock did sore initially after the news about these results, but then it gave up all of those gains.

We don’t know exactly what the FDA is thinking here. I do think this news does bolster the case for NRx’s drug, but we’ll see. I do think it’s too soon to say whether or not this is the biggest news so far in treating severe COVID-19. It is important to know what we don’t know. We don’t know what concerns the FDA might have beyond what we’ve seen in the press. NRx even mentioned that it’s continuing to respond to FDA information request for additional data related to its EUA filing.

The News Highlights

  • Could this be the biggest news in the treatment of severe COVID so far?
  • Check the latest Health news updates and information about health.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
Can Microsoft’s foldable improve enough for us to recommend it?
Can Microsoft’s foldable improve enough for us to recommend it?
The Surface Duo is a compelling first generation folding phone, but a lack of software optimisation and some dated specs hold it back. Nonetheless, there’s ...
Fitness business opens on Center Street in Ashtabula |  local news
Fitness business opens on Center Street in Ashtabula | local news
“I’ve been in fitness for a very long time,” Anderson said. She said she started her classes in the back yard of her home, worked out of a building near the ...
The iPhone 13 may be Apple’s most expensive iPhone ever, which is bad news
The iPhone 13 may be Apple’s most expensive iPhone ever, which is bad news
The changes are expected to go into effect in January 2022, but it is said that Apple might attempt to offset those costs by factoring that into the price of ...
Death of an unvaccinated woman blamed for her death in COVID
Death of an unvaccinated woman blamed for her death in COVID
While preparing her obituary, the woman’s relatives decided they wanted to share a message that they believe Ayers would have approved of. “I wish there was ...
If it isn’t broken, don’t fix it
If it isn’t broken, don’t fix it
And yet I still consider this laptop to be near the top of its class. A few quibbles aside, it’s one of the easiest to recommend laptops on the market. I ...
The Xbox executive picks his favourite GameCube game, which is considered one of Nintendo’s best-kept secrets
The Xbox executive picks his favourite GameCube game, which is considered one of Nintendo’s best-kept secrets
A perfect paintings that was once left with no sequel regardless of mesmerizing the avid gamersThe charismatic Xbox boss replied an account asking in regards ...
The Covid-19 Asia increase poses a challenge to the production of ceramic bits for iPhone and PlayStation
The Covid-19 Asia increase poses a challenge to the production of ceramic bits for iPhone and PlayStation
They are called MLCCs in the sense of multi-layer ceramic capacitors, and the proliferation of Covid-19 infections throughout East Asia increases the risk ...
Marshall Bolsters Its True Wireless Earbuds Lineup With The Motif A.N.C.
Marshall Bolsters Its True Wireless Earbuds Lineup With The Motif A.N.C.
Among the TWS earphones Men’s Gear has been featuring so far, we’re loving the manufacturer’s aesthetic direction here. Much like the majority of its ...
France seeks European support after surprise in submarine deal
France seeks European support after surprise in submarine deal
French Foreign Minister Jean-Yves Le Drian, in New York to represent France at the U.N. General Assembly, is expected to give a news conference Monday to ...
SSD Wins Emmy for Outstanding Comedy Series as Apple TV+ Captures 11 Total Awards
SSD Wins Emmy for Outstanding Comedy Series as Apple TV+ Captures 11 Total Awards
Despite retaining the ability to upgrade your own SSD, ever since Apple introduced their proprietary “blade” SSDs in 2010, the task hasn’t been as simple as ...
Show next
Compsmag - Latest News from tech, business and health
Logo